Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-26 Purchase | 2022-08-30 4:45 pm | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,000 | $15.75 | $15,750 | 5,000 (Direct) | View |
| 2022-08-19 Purchase | 2022-08-23 4:45 pm | OptimizeRx Corp | OPRX | Lang James Paul Director | 6,000 | $16.45 | $98,723 | 38,660 (Direct) | View |
| 2022-08-19 Purchase | 2022-08-23 4:45 pm | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 16,100 | $15.59 | $251,005 | 461,772 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-17 4:46 pm | OptimizeRx Corp | OPRX | Silvestro Stephen L CCO | 3,200 | $15.66 | $50,112 | 3,200 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-17 4:45 pm | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 500 | $15.91 | $7,955 | 500 (Direct) | View |
| 2022-08-15 Purchase | 2022-08-17 4:45 pm | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 3,000 | $15.43 | $46,290 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-18 Option Award | 2023-04-20 3:15 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 248,383 | $0 | 248,383 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 657 | $0 | 40,717 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 657 | $0 | 66,885 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 657 | $0 | 19,988 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 657 | $0 | 18,140 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-03 12:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 657 | $0 | 35,447 (Direct) | View |
| 2022-10-11 Tax Withholding | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 6,539 | $15.17 | 21,125 (Direct) | View |
| 2022-10-11 Exercise | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,221 | $0 | 21,125 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:41 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 771 | $0 | 10,698 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:41 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 268 | $18.11 | 10,698 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 8,314 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:40 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 668 | $18.11 | 8,314 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 3:31 pm | N/A N/A | OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer | 771 | $0 | 2,080 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 3:31 pm | N/A N/A | OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer | 233 | $18.11 | 2,080 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 11:32 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 20,653 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 11:32 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,422 | $17.34 | 20,653 (Direct) | View |
| 2023-01-07 Exercise | 2023-01-31 4:50 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 9,628 | $0 | 481,028 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:10 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 409 | $0 | 65,571 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:07 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 409 | $0 | 18,674 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:06 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 409 | $0 | 34,133 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:04 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 409 | $0 | 16,826 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:04 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 409 | $0 | 39,403 (Direct) | View |
| 2022-11-08 Tax Withholding | 2022-11-10 3:29 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 710 | $14.52 | 9,645 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 3:29 pm | N/A 2024-11-08 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,785 | $0 | 9,645 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 59,002 | $0 | 59,002 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:17 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 147,504 | $0 | 147,504 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:15 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 59,002 | $0 | 59,002 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:14 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 29,500 | $0 | 29,500 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:13 pm | N/A N/A | OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer | 29,500 | $0 | 29,500 (Direct) | View |
Ownership | 2022-10-03 2:57 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 0 | $0 | 16,500 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:48 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 334 | $0 | 16,417 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 334 | $0 | 38,994 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:44 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 334 | $0 | 65,162 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:39 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 334 | $0 | 18,265 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:37 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 334 | $0 | 33,724 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 4,637 | $0 | 4,637 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 4,637 | $0 | 4,637 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 4,637 | $0 | 4,637 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 4,637 | $0 | 4,637 (Direct) | View |